NCT03843892 An Expanded Access Program to Provide Nintedanib to Patients With Non-IPF ILD Who Have no Alternative Treatment Possibilities Status APPROVED_FOR_MARKETING Phase N/A
NCT03843151 A Study in Healthy Men to Test How Itraconazole Influences the Amount of BI 1358894 in the Blood Status COMPLETED Phase PHASE1
NCT03842761 A Study to Test How Different Doses of BI 685509 Are Tolerated in Patients With Liver Problems Status COMPLETED Phase PHASE1
NCT03837964 A Study to Test How Food Influences the Amount of BI 1291583 in the Blood of Healthy Men Status COMPLETED Phase PHASE1
NCT03835481 A Study to Test How Well Patients With Plaque Psoriasis Tolerate BI 730357 Over a Longer Period and How Effective it is Status TERMINATED Phase PHASE2
NCT03822832 A Study in Patients With Atopic Eczema to Test How Effective BI 655130 is and How Well it is Tolerated Status COMPLETED Phase PHASE2
NCT03820726 A Follow-up Study Investigating Long Term Treatment With Nintedanib in Patients With Progressive Fibrosing Interstitial Lung Disease (PF-ILD) Status COMPLETED Phase PHASE3
NCT03817476 A Study in Healthy People to Test if Taking Different Formulations of BI 425809 Tablets Influences the Amount of BI 425809 in the Blood Status COMPLETED Phase PHASE1
NCT03817463 A Study to Observe the Effectiveness of Empagliflozin, Other SGLT-2 Inhibitors, or DPP-4 Inhibitors in Patients With Type 2 Diabetes Status COMPLETED Phase N/A
NCT03804671 A Study in Healthy Men to Measure the Amount of BI 730357 in the Blood When Taken as a Tablet Status COMPLETED Phase PHASE1
NCT03802331 A Study to Test How Food Influences the Amount of BI 1323495 in the Blood of Healthy Men Status COMPLETED Phase PHASE1
NCT03794323 A Study in Healthy Men to Find Out How Well Different Doses of BI 764122 Are Tolerated and Whether Food Affects the Amount of BI 764122 in the Blood Status COMPLETED Phase PHASE1
NCT03793621 This Study is Done in Healthy Japanese Volunteers. It Looks at How Different Doses of BI 730357 Are Taken up in the Body and How Well They Are Tolerated Status COMPLETED Phase PHASE1
NCT03783000 A Study in Healthy Men to Measure the Amount of BI 425809 in the Blood When Taken as a Tablet Status COMPLETED Phase PHASE1
NCT03782987 A Study in Healthy Men to Test How Itraconazole Influences the Amount of BI 730357 in the Blood Status COMPLETED Phase PHASE1
NCT03782792 Effisayil™ 1: A Study to Test Spesolimab (BI 655130) in Patients With a Flare-up of a Skin Disease Called Generalized Pustular Psoriasis Status COMPLETED Phase PHASE2
NCT03780725 This Study Tests How BI 754111 is Distributed in Patients With Advanced Non-small Cell Lung Cancer or Patients With Head and Neck Cancer Who Are Treated With BI 754091 Status TERMINATED Phase PHASE1
NCT03771885 BI 705564 in Patients With Systemic Lupus Erythematosus (SLE) Status WITHDRAWN Phase PHASE1